Physician profile
Khalid Mohammad
NPI 1619139672
$11,479.96
in general payments reported to CMS, 2019-2025
31 companies · $299 in 2025
The $299 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $770 · 2020: $287 · 2021: $644 · 2022: $166 · 2023: $5,608 · 2024: $3,705 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,213 · Travel and Lodging: $2,584 · Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,212.75 |
| Travel and Lodging | $2,583.59 |
| Food and Beverage | $815.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,953.60 | 2023-2025 | Ion, Da Vinci Surgical System |
| Steris Corporation | $1,800.33 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $410.21 | 2019-2022 | |
| Merit Medical Systems INC | $353.30 | 2024 | Aero Stent and Delivery System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $228.19 | 2019-2021 | |
| Glaxosmithkline, LLC. | $195.50 | 2019-2024 | Trelegy Ellipta |
| Mallinckrodt Hospital Products INC. | $158.59 | 2020-2022 | |
| Amgen INC. | $137.41 | 2019-2025 | Tezspire |
| Medtronic, INC. | $129.44 | 2023-2025 | Hawkone, Illumisite |
| Shockwave Medical, INC | $112.88 | 2025 | |
| Mallinckrodt Enterprises LLC | $104.76 | 2019 | |
| Novartis Pharmaceuticals Corporation | $96.58 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $96.40 | 2019 | |
| Sunovion Pharmaceuticals INC. | $89.83 | 2019 | |
| Genzyme Corporation | $88.46 | 2019-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $62.70 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Merck Sharp & Dohme LLC | $59.54 | 2019-2023 | |
| Ethicon INC. | $55.44 | 2021 | |
| Janssen Pharmaceuticals, INC | $44.61 | 2019-2021 | |
| Abiomed | $39.42 | 2023-2024 | Impella |
| Regeneron Healthcare Solutions, INC. | $35.69 | 2019 | |
| Insmed, INC. | $31.96 | 2020-2021 | |
| Tactile Systems Technology INC | $29.11 | 2021 | |
| Genentech USA, INC. | $28.38 | 2021-2022 | |
| Pinnacle Biologics, INC | $27.79 | 2024 | Photofrin |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.40 | 2019 | |
| Inspire Medical Systems, INC. | $21.30 | 2025 | Inspire |
| Cordis US Corp. | $20.46 | 2025 | Mynx Control Venous |
| Boston Scientific Corporation | $17.84 | 2021 | |
| Advanced Respiratory, INC | $14.43 | 2020 | |
| Pfizer INC. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Mohammad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.